Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity

[11] Kwakowsky A(2016)MMP-9 in translation: from molecule to brain physiology, pathology, and therapy J Neurochem 139 91-1318

[12] Grammas P(2003)Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system Brain Res Bull 61 347-196

[13] Ringland C(2009)Increased matrix metalloproteinase 9 activity in mild cognitive impairment J Neuropathol Exp Neurol 68 1309-76

[14] Schweig JE(2003)Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s disease Neurochem Int 43 191-1691

[15] Paris D(2008)Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia Int Psychogeriatr 20 67-15091

[16] Shackleton B(2020)Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer’s disease Ann Clin Transl Neurol 7 1681-189

[17] Lynch CE(2015)Sequential amyloid-β degradation by the matrix metalloproteases MMP-2 and MMP-9 J Biol Chem 290 15078-8305

[18] Eisenbaum M(2014)Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer’s 5xFAD mice Neurobiol Dis 70 179-476

[19] Vandooren J(2019)Influence of matrix metallopeptidase 9 on beta-amyloid elimination across the blood-brain barrier Mol Neurobiol 56 8296-569

[20] Van Damme J(2012)Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation Exp Neurol 237 470-1083

[11] Kwakowsky A(2016)MMP-9 in translation: from molecule to brain physiology, pathology, and therapy J Neurochem 139 91-1318

[12] Grammas P(2003)Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system Brain Res Bull 61 347-196

[13] Ringland C(2009)Increased matrix metalloproteinase 9 activity in mild cognitive impairment J Neuropathol Exp Neurol 68 1309-76

[14] Schweig JE(2003)Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s disease Neurochem Int 43 191-1691

[15] Paris D(2008)Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia Int Psychogeriatr 20 67-15091

[16] Shackleton B(2020)Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer’s disease Ann Clin Transl Neurol 7 1681-189

[17] Lynch CE(2015)Sequential amyloid-β degradation by the matrix metalloproteases MMP-2 and MMP-9 J Biol Chem 290 15078-8305

[18] Eisenbaum M(2014)Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer’s 5xFAD mice Neurobiol Dis 70 179-476

[19] Vandooren J(2019)Influence of matrix metallopeptidase 9 on beta-amyloid elimination across the blood-brain barrier Mol Neurobiol 56 8296-569

[20] Van Damme J(2012)Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation Exp Neurol 237 470-1083